- Article metrics
- Last updated: Fri, 30 Jan 2026 15:19:59 Z
A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC)
Access & Citations
-
- 749
- Article Accesses
-
- 9
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
